Potent new pill provides COVID relief for the masses

Saima Sidik

Nature, 2024, vol. 625, issue 7996, 644-644

Abstract: The drug simnotrelvir shortens symptoms for those with mild infections and is sold at a lower price in China than its main rival.

Keywords: Medical research; SARS-CoV-2; Virology; Public health (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-00117-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:625:y:2024:i:7996:d:10.1038_d41586-024-00117-5

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-00117-5

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().